vs
Amarin Corp plc（AMRN）与Clearfield, Inc.（CLFD）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Clearfield, Inc.的1.3倍（$45.1M vs $34.3M），Clearfield, Inc.净利率更高（-1.8% vs -23.3%，领先21.5%），Amarin Corp plc同比增速更快（7.0% vs -3.2%），过去两年Clearfield, Inc.的营收复合增速更高（-3.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
AMRN vs CLFD — 直观对比
营收规模更大
AMRN
是对方的1.3倍
$34.3M
营收增速更快
AMRN
高出10.2%
-3.2%
净利率更高
CLFD
高出21.5%
-23.3%
两年增速更快
CLFD
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $34.3M |
| 净利润 | $-10.5M | $-614.0K |
| 毛利率 | — | 33.2% |
| 营业利润率 | 35.5% | -5.3% |
| 净利率 | -23.3% | -1.8% |
| 营收同比 | 7.0% | -3.2% |
| 净利润同比 | 33.0% | 67.8% |
| 每股收益（稀释后） | — | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCLFD
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $34.3M | ||
| Q3 25 | $49.7M | $23.4M | ||
| Q2 25 | $72.7M | $49.9M | ||
| Q1 25 | $42.0M | $47.2M | ||
| Q4 24 | $62.3M | $29.7M | ||
| Q3 24 | $42.3M | $5.6M | ||
| Q2 24 | $67.5M | $48.8M |
净利润AMRNCLFD
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-614.0K | ||
| Q3 25 | $-7.7M | $-9.1M | ||
| Q2 25 | $-14.1M | $1.6M | ||
| Q1 25 | $-15.7M | $1.3M | ||
| Q4 24 | $-48.6M | $-1.9M | ||
| Q3 24 | $-25.1M | — | ||
| Q2 24 | $1.5M | $-447.0K |
毛利率AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 33.2% | ||
| Q3 25 | 44.7% | 53.2% | ||
| Q2 25 | 69.2% | 30.5% | ||
| Q1 25 | 59.8% | 30.1% | ||
| Q4 24 | -15.4% | 29.2% | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | 21.9% |
营业利润率AMRNCLFD
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -5.3% | ||
| Q3 25 | -22.4% | 10.3% | ||
| Q2 25 | -22.0% | 3.0% | ||
| Q1 25 | -39.9% | 0.6% | ||
| Q4 24 | -84.3% | -6.9% | ||
| Q3 24 | -59.5% | — | ||
| Q2 24 | -0.8% | -4.7% |
净利率AMRNCLFD
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -1.8% | ||
| Q3 25 | -15.6% | -38.8% | ||
| Q2 25 | -19.4% | 3.2% | ||
| Q1 25 | -37.4% | 2.8% | ||
| Q4 24 | -78.0% | -6.4% | ||
| Q3 24 | -59.4% | — | ||
| Q2 24 | 2.3% | -0.9% |
每股收益（稀释后）AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.04 | ||
| Q3 25 | $-0.02 | $-0.65 | ||
| Q2 25 | $-0.03 | $0.11 | ||
| Q1 25 | $-0.04 | $0.09 | ||
| Q4 24 | $-0.12 | $-0.13 | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $0.00 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $96.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $249.7M |
| 总资产 | $645.8M | $268.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNCLFD
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $96.4M | ||
| Q3 25 | $286.6M | $106.0M | ||
| Q2 25 | $298.7M | $117.2M | ||
| Q1 25 | $281.8M | $112.0M | ||
| Q4 24 | $294.2M | $113.0M | ||
| Q3 24 | $305.7M | $129.0M | ||
| Q2 24 | $306.7M | $123.8M |
总债务AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.1M |
股东权益AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $249.7M | ||
| Q3 25 | $458.9M | $256.2M | ||
| Q2 25 | $464.9M | $264.5M | ||
| Q1 25 | $473.7M | $265.9M | ||
| Q4 24 | $486.2M | $267.4M | ||
| Q3 24 | $531.4M | $275.8M | ||
| Q2 24 | $551.9M | $274.6M |
总资产AMRNCLFD
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $268.1M | ||
| Q3 25 | $659.8M | $306.2M | ||
| Q2 25 | $670.1M | $314.7M | ||
| Q1 25 | $655.7M | $310.9M | ||
| Q4 24 | $685.3M | $303.2M | ||
| Q3 24 | $750.6M | $315.3M | ||
| Q2 24 | $799.9M | $318.1M |
负债/权益比AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.4M |
| 自由现金流率自由现金流/营收 | — | -7.1% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-1.4M | ||
| Q3 25 | $-12.7M | — | ||
| Q2 25 | $16.6M | $7.9M | ||
| Q1 25 | $-12.5M | $3.0M | ||
| Q4 24 | $-13.3M | $7.2M | ||
| Q3 24 | $-2.4M | $22.2M | ||
| Q2 24 | $-2.7M | $4.0M |
自由现金流AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $654.0K | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $18.2M | ||
| Q2 24 | — | $2.8M |
自由现金流率AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | -7.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 15.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 323.0% | ||
| Q2 24 | — | 5.8% |
资本支出强度AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 2.5% |
现金转化率AMRNCLFD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CLFD
暂无分部数据
